Concentrix Corp.

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: US20602D1019
USD
26.48
-6.56 (-19.85%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.29 M

Shareholding (Nov 2025)

FII

28.25%

Held by 149 FIIs

DII

20.47%

Held by 45 DIIs

Promoter

14.13%

How big is Concentrix Corp.?

22-Jun-2025

As of Jun 18, Concentrix Corp. has a market capitalization of 3,572.36 million, with net sales of 9,588.37 million and net profit of 257.79 million over the latest four quarters.

As of Jun 18, Concentrix Corp. has a market capitalization of 3,572.36 million, categorizing it as a Mid Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 9,588.37 million, while the sum of Net Profit for the same period is 257.79 million.<BR><BR>As of Nov'24, the reporting period shows Shareholder's Funds at 4,039.72 million and Total Assets at 11,991.44 million.

View full answer

What does Concentrix Corp. do?

22-Jun-2025

Concentrix Corp. is a mid-cap company in the Miscellaneous industry, with recent net sales of $2.372 billion and a net profit of $67 million. Key metrics include a P/E ratio of 11.00, a dividend yield of 0.60%, and a market cap of $3.572 billion.

Overview:<BR>Concentrix Corp. operates in the Miscellaneous industry and is classified as a mid-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 2,372 Million (Quarterly Results - Feb 2025) <BR>Most recent Net Profit: 67 Million (Quarterly Results - Feb 2025) <BR>Market cap: USD 3,572.36 Million (Mid Cap)<BR><BR>Key Metrics:<BR>P/E: 11.00 <BR>Dividend Yield: 0.60% <BR>Debt Equity: 1.16 <BR>Return on Equity: 8.39% <BR>Price to Book: 0.89 <BR><BR>Contact Details:<BR>Registrar Address: Not available.

View full answer

Should I buy, sell or hold Concentrix Corp.?

22-Jun-2025

Is Concentrix Corp. technically bullish or bearish?

07-Oct-2025

As of October 3, 2025, Concentrix Corp. shows a mildly bullish technical trend despite mixed signals, having underperformed the S&P 500 recently but maintaining a positive year-to-date return.

As of 3 October 2025, the technical trend for Concentrix Corp. has changed from mildly bearish to mildly bullish. The weekly MACD is bearish, but the monthly MACD shows a mildly bullish stance. The weekly RSI indicates bullish momentum, while the monthly RSI has no signal. Daily moving averages are mildly bullish, contrasting with the weekly Bollinger Bands, which are bearish, and the monthly Bollinger Bands, which are mildly bearish. The KST is bearish on a weekly basis but mildly bullish monthly. Dow Theory shows no trend in both weekly and monthly assessments.<BR><BR>Concentrix has underperformed the S&P 500 across multiple periods, with a 1-week return of -0.61% compared to the S&P 500's 1.09%, and a 1-month return of -11.67% versus the S&P 500's 4.15%. However, it has a positive year-to-date return of 9.87%, while the S&P 500 has returned 14.18%. Overall, the current technical stance is mildly bullish, but the mixed signals suggest caution.

View full answer

Is Concentrix Corp. overvalued or undervalued?

05-Nov-2025

As of October 31, 2025, Concentrix Corp. is considered undervalued with attractive valuation metrics, including a P/E ratio of 11, despite underperforming the S&P 500 with a year-to-date return of -9.87%.

As of 31 October 2025, the valuation grade for Concentrix Corp. has moved from fair to attractive, indicating a positive shift in its valuation outlook. The company appears undervalued relative to its peers, with a P/E ratio of 11, a Price to Book Value of 0.90, and an EV to EBITDA of 5.71. In comparison, Genpact Ltd. has a P/E of 14.38 and an EV to EBITDA of 10.34, while ADT, Inc. shows a P/E of 10.02 and an EV to EBITDA of 5.12, highlighting Concentrix's more favorable valuation metrics.<BR><BR>Despite its attractive valuation, Concentrix has underperformed against the S&P 500 across multiple time frames, with a year-to-date return of -9.87% compared to the S&P 500's 16.30%. This underperformance may suggest that the market has not yet recognized the company's potential, reinforcing the notion that Concentrix is undervalued.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Healthy long term growth as Net Sales has grown by an annual rate of 15.80% and Operating profit at 17.40%

 
2

Flat results in Nov 25

3

Risky -

4

Reducing Promoter Confidence

5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 1,972 Million (Small Cap)

stock-summary
P/E

6.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

4.44%

stock-summary
Debt Equity

1.59

stock-summary
Return on Equity

11.99%

stock-summary
Price to Book

0.72

Revenue and Profits:
Net Sales:
2,553 Million
(Quarterly Results - Nov 2025)
Net Profit:
-1,474 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-36.48%
0%
-36.48%
6 Months
-52.37%
0%
-52.37%
1 Year
-41.16%
0%
-41.16%
2 Years
-56.78%
0%
-56.78%
3 Years
-77.49%
0%
-77.49%
4 Years
-86.46%
0%
-86.46%
5 Years
-79.42%
0%
-79.42%

Concentrix Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
15.80%
EBIT Growth (5y)
17.40%
EBIT to Interest (avg)
8.89
Debt to EBITDA (avg)
2.54
Net Debt to Equity (avg)
1.08
Sales to Capital Employed (avg)
0.99
Tax Ratio
16.17%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
11.33%
ROE (avg)
11.93%

Valuation key factors

Factor
Value
P/E Ratio
6
Industry P/E
Price to Book Value
0.72
EV to EBIT
8.81
EV to EBITDA
4.61
EV to Capital Employed
0.89
EV to Sales
0.65
PEG Ratio
1.32
Dividend Yield
4.44%
ROCE (Latest)
10.11%
ROE (Latest)
11.99%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Nov 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 81 Schemes (37.14%)

Foreign Institutions

Held by 149 Foreign Institutions (28.25%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Nov'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Nov 2025 is 4.29% vs 9.75% in Nov 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Nov 2025 is -1,432.55% vs 63.13% in Nov 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Nov'25",
        "Nov'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,552.90",
          "val2": "2,448.00",
          "chgp": "4.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "360.80",
          "val2": "372.10",
          "chgp": "-3.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "69.90",
          "val2": "76.10",
          "chgp": "-8.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,569.20",
          "val2": "-19.80",
          "chgp": "-7,825.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1,473.80",
          "val2": "110.60",
          "chgp": "-1,432.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "77.40%",
          "val2": "84.10%",
          "chgp": "-0.67%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Nov'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Nov 2025 is 2.15% vs 35.20% in Nov 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Nov 2025 is -630.82% vs -21.47% in Nov 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Nov'25",
        "Nov'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9,825.80",
          "val2": "9,618.90",
          "chgp": "2.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,380.60",
          "val2": "1,463.90",
          "chgp": "-5.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "290.30",
          "val2": "321.80",
          "chgp": "-9.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,624.10",
          "val2": "-117.60",
          "chgp": "-1,281.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1,283.00",
          "val2": "241.70",
          "chgp": "-630.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "73.30%",
          "val2": "78.80%",
          "chgp": "-0.55%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Nov'25 - YoYstock-summary

Nov'25
Nov'24
Change(%)
Net Sales
2,552.90
2,448.00
4.29%
Operating Profit (PBDIT) excl Other Income
360.80
372.10
-3.04%
Interest
69.90
76.10
-8.15%
Exceptional Items
-1,569.20
-19.80
-7,825.25%
Consolidate Net Profit
-1,473.80
110.60
-1,432.55%
Operating Profit Margin (Excl OI)
77.40%
84.10%
-0.67%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Nov 2025 is 4.29% vs 9.75% in Nov 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Nov 2025 is -1,432.55% vs 63.13% in Nov 2024

Annual Results Snapshot (Consolidated) - Nov'25stock-summary

Nov'25
Nov'24
Change(%)
Net Sales
9,825.80
9,618.90
2.15%
Operating Profit (PBDIT) excl Other Income
1,380.60
1,463.90
-5.69%
Interest
290.30
321.80
-9.79%
Exceptional Items
-1,624.10
-117.60
-1,281.04%
Consolidate Net Profit
-1,283.00
241.70
-630.82%
Operating Profit Margin (Excl OI)
73.30%
78.80%
-0.55%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Nov 2025 is 2.15% vs 35.20% in Nov 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Nov 2025 is -630.82% vs -21.47% in Nov 2024

stock-summaryCompany CV
About Concentrix Corp. stock-summary
stock-summary
Concentrix Corp.
Miscellaneous
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available